Back to News
Market Impact: 0.32
Medtronic: Don't Miss Out On This Dividend Aristocrat Deal Now
Source: seekingalpha.com
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Medtronic outperformed the S&P 500 in recent months and delivered a strong Q1 FY2027 performance, prompting an increase in its non-GAAP EPS guidance for the full fiscal year. The company’s healthy interest-coverage and net-debt-to-EBITDA ratios support a favorable financial-risk profile alongside improving earnings expectations.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
MDT0.72
More News
- He went from washing lab equipment for $10 an hour to leading a $30 billion healthcare company. His advice to Gen Z: Raise your hand
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- The AI ‘credit card’ is getting costlier as CoreWeave bond yield tops 16%
- OpenAI to press ahead with data-center expansion despite midterm sweep, CFO tells CNBC
- Elanco Shares Jump After Q3 Beat and Outlook Raise